CAS 288383-20-0,Recentin(GP6207)

Basic Info

Model No.: 288383-20-0

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Product Description

CAS # 288383-20-0,Cediranib (AZD2171) We hold the expertise to offer a range of Cediranib CAS 288383-20-0 which is a Antineoplastic. Cediranib CAS NO 288383-20-0, also known as AZD2171, is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. We can also provide free sample to meet customers requirement. Patrons can avail this range according to their demands and requirements.

Thera. Category: A tyrosine kinase inhibitor

Cas No.: 288383-20-0

Synonym: Cediranib;4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline;Cadiranib (AZD2171);Cediranib(AZD2171);AZD2171;Recentin;Cadiranib;Cediranib R

Molecular Formula: C25H27FN4O3

Molecular Weight: 450.51

Assay: ≥98.%

Appearance: Crystalline solid

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Solubility:DMSO (10 mM)

Storage Temp.: -20°C

Shipping Conditions: RT

Handling: Protect from air and moisture

Related Intermediates:

1)CAS # 288383-20-0,Cediranib (AZD2171)

2) CAS #288385-88-6,4-Fluoro-5-hydroxy-2-methylindole

Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.